Companies / Globus Medical Inc
Globus Medical Inc
Insider flow · last 90 daysNet sells $2.02M
Financials · FY2025
Ownership
134.3M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 0.42% | 560,978 |
| 10%+ / strategic | 4.38% | 5,885,560 |
| Institutions | 85.71% | 115,077,791 |
| Public float | 9.49% | 12,737,585 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
Davidar David DDirector | 0.38% | 510,175 |
Rhoads Ann DDirector | 0.03% | 40,384 |
Norwalk Leslie VDirector | <0.01% | 10,419 |
Huller KellyEVP, GC, Corporate Secretary | 0.00% | 0 |
Kline KyleSenior Vice President, CFO | 0.00% | 0 |
DeFord John AFormerDirector | — | — |
Douglas Robert AndrewDirector | — | — |
Lemaitre DanFormerDirector | — | — |
Paul David CExecutive Chairman · Director · 10% owner | — | — |
Pfeil Keith WCEOPresident, CEO · Director | — | — |
Institutional holders 575
View all →| Holder | Value | % of shares |
|---|---|---|
| $921.07M | 7.86% | |
| $853.84M | 8.05% | |
| $656.83M | 5.68% | |
| $339.32M | 2.89% | |
| $294.52M | 2.51% | |
| $293.54M | 2.77% | |
| $270.55M | 2.31% | |
| $263.48M | 2.28% | |
| $229.17M | 1.95% | |
| $221.71M | 1.89% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Sculptor Capital LP 13F manager | New | Common stock | $261.93M | +3.0M | 3,000,000 2.23% of shares | high |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $121.40M | +1.4M +601.33% | 1,643,352 1.22% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-89.92M | -1.0M -100.00% | 0 | high |
| Q1 2023 as of | Barclays PLC 13F manager | Add | Common stock | $67.98M | +1.2M +9332.51% | 1,213,115 0.90% of shares | high |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $62.01M | +729K +617.09% | 846,778 0.63% of shares | high |
| Q2 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-48.58M | -816K -67.26% | 397,203 0.30% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $41.29M | +523K +5.08% | 10,806,724 8.05% of shares | medium |
| Q1 2026 as of | Arrowstreet Capital, Limited Partnership 13F manager | Add | Common stock | $40.66M | +472K +106.99% | 912,905 0.68% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Capital Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| GMED | — | 379577208 |